$0.618065
-0.07-10.52%
At close: -
$0.610100
-0.0080-1.29%
After Hours: Nov 14, 8:59 AM EDT
Comments
Loading...
Protagenic Therapeutics (NASDAQ:PTIX) Stock, Earnings Estimates, EPS, And Revenue
Protagenic Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 14
EPS
$-0.360
Quarterly Revenue
$0K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of Protagenic Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Protagenic Therapeutics (PTIX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2021 | 2021-11-16 | $-0.20 | $-0.36 | 44.4 % |
Protagenic Therapeutics (PTIX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Protagenic Therapeutics (NASDAQ:PTIX) reporting earnings?
Protagenic Therapeutics (PTIX) is scheduled to report earnings on November 29, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
What were the latest earnings per share (EPS) for Protagenic Therapeutics (NASDAQ:PTIX)?
The Actual EPS was $-0.36, which missed the estimate of $0.00.
What were Protagenic Therapeutics’s (NASDAQ:PTIX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.